v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Statement of Cash Flows [Abstract]      
Net loss $ (58,092) $ (15,625) $ (25,607)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation 342 228 237
Share-based compensation 2,211 439 411
Warrants to service providers 115 52 58
Revaluation of warrants and accretion 6,599 1,106 26
Revaluation of convertible loan 17,866 184
Change in operating assets and liabilities:      
Increase in trade receivable (50) (137)
Decrease (increase) in prepaid expenses and other receivables (2,228) (371) 556
Increase (decrease) in trade payables 458 (1,063) 692
Increase in employees and payroll accruals 1,557 367 398
Increase in deferred revenue 445 75 206
Increase (decrease) in accrued expenses and other payables 4,361 (356) 280
Net cash used in operating activities (26,416) (15,285) (22,559)
Cash flows from investing activities:      
Change in bank deposits 100 9,860 (8,310)
Purchase of property and equipment (784) (156) (227)
Net cash provided by (used in) investing activities (684) 9,704 (8,537)
Cash flows from financing activities:      
Proceeds from long-term loan and warrants for the purchase of Series B-1 redeemable convertible preferred shares, net of issuance costs of $50 4,764
Proceeds from short-term loan 4,715
Repayment of long-term loan (2,639) (1,585) (560)
Proceeds from issuance of redeemable convertible preferred shares and warrants for the purchase of Series B-2 redeemable convertible preferred shares, net of 2019 issuance costs of $230 1,190 31,341
Proceeds from recapitalization and PIPE offering, net of issuance costs 98,587
Proceeds from exercise of warrants 12,859 256
Proceeds from exercise of options 223 30 [1]
Proceeds from convertible loan 11,337 1,641
Net cash provided by financing activities 125,082 1,532 35,545
Increase (decrease) in cash, cash equivalents and restricted cash 97,982 (4,049) 4,449
Cash, cash equivalents and restricted cash at the beginning of the year 2,954 7,003 2,554
Cash, cash equivalents and restricted cash at the end of the year 100,936 2,954 7,003
Supplemental non-cash disclosure:      
Exercise of warrants into convertible preferred shares 4,389 85
Issuance of private warrants 6,598
Conversion of convertible loan into preferred shares 10,447
Conversion of convertible loan into ordinary shares upon the recapitalization 30,844
Conversion of preferred shares into ordinary shares upon the recapitalization 63,467
Purchase of property and equipment 340
Supplemental disclosure of cash flows activities:      
Interest paid $ 209 $ 411 $ 259
[1] Represents less than $1.

Source